1. Alivus Life Sciences Ltd.
  2. Alivus Life Sciences Ltd. Shareholdings

Historical shareholding details of GLENMARK PHARMACEUTICALS LIMITED holdings in Alivus Life Sciences Ltd. (ALIVUS)

Quarterly changes of GLENMARK PHARMACEUTICALS LIMITED shareholding in Alivus Life Sciences Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Sep 2024 Glenmark Pharmaceuticals Limited 0 0.00% 0 0.00% 0 0.00%
Jun 2024 Glenmark Pharmaceuticals Limited 9,609,571 7.84% 9,609,571 100.00% 0 0.00%
Mar 2024 Glenmark Pharmaceuticals Limited 9,609,571 7.84% 9,609,571 100.00% 0 0.00%
Dec 2023 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 9,609,571 9.47% 24,505,435 24.14%
Sep 2023 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 9,609,571 9.47% 24,505,435 24.14%
Jun 2023 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 24,505,435 24.14%
Mar 2023 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 24,505,435 24.14%
Dec 2022 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 24,505,435 24.14%
Sep 2022 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 24,505,435 24.14%
Jun 2022 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 101,504,950 100.00%
Mar 2022 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 101,504,950 100.00%
Dec 2021 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 101,504,950 100.00%
Sep 2021 Glenmark Pharmaceuticals Limited 101,504,950 82.84% 0 0.00% 101,504,950 100.00%

View all shareholdings details of Alivus Life Sciences Ltd.